ProCE Banner Activity

All-BARI-RA Updated Findings: Long-term Safety of Baricitinib in Patients With Rheumatoid Arthritis

Slideset Download
Conference Coverage
Baricitinib safety through 7 years acceptable and similar to that previously reported.

Released: November 25, 2019

Expiration: November 23, 2020

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead

Mallinckrodt Pharmaceuticals